Skip to main content
    I

    Intensity Therapeutics, Inc. Common stock (INTS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.66
    -0.41 (-13.36%)

    Market Cap: $10.13M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Intensity Therapeutics, Inc. Common stock (INTS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Intensity Therapeutics, Inc. Common stock (INTS) has a latest price of $2.66 on Nov 17, 2026. Its price fell 75.7% over the past 12 months. The month-end price fell 95.5% over the 3 years through Oct 2026, a compound annual decline of 64.5%.

    Price Chart

    From Jun 2023 to Oct 2026, its highest month-end close was $214.25 in Dec 2023 and its lowest $3.37 in Sep 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart INTS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INTS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 36.7%, and over 6 months it fell 42.0%.

    PeriodChange
    1 month-19.1%
    3 months-36.7%
    6 months-42.0%
    12 months-75.7%
    12 months, with dividends-75.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-95.5%-64.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price fell 76.7%, and its weakest was 2024, when it fell 79.5%.

    YearCloseChange
    2026 through Oct 2026$3.40-66.8%
    2025$10.26-76.7%
    2024$44.00-79.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 23.6% below its 50-day average of $3.48 and 44.9% below its 200-day average of $4.83.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.66
    50-day average$3.48-23.6%
    200-day average$4.83-44.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 98.9%.

    MeasureValue
    1-year beta1.36
    Largest fall, 1 year-82.0%
    Largest fall, 3 years-98.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About INTS

    What is INTS's 1-year price change?

    Intensity Therapeutics, Inc. Common stock's price fell 75.7% over the past 12 months. With dividends included, the 12-month total return was -75.7%.

    How has INTS stock done over the long term?

    Intensity Therapeutics, Inc. Common stock's month-end price fell 95.5% over the 3 years through Oct 2026, a compound annual decline of 64.5%. These figures leave out dividends.

    What is INTS's beta?

    Intensity Therapeutics, Inc. Common stock's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 82.0%.

    Is the INTS chart free?

    Yes. Advanced Charting for INTS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.